Anlon Healthcare IPO GMP Today ₹5 Get the Latest Updates on Anlon Healthcare ipo Grey market premium (GMP), Kostak rate, and Subject to Sauda Price along with Expected Listing Gains. Track daily GMP trends and IPO details before investing.
Latest Anlon Healthcare IPO GMP (Grey Market Premium)
Anlon Healthcare IPO GMP Today is – ₹5 Per Share
Kostak Rate – Not Available
Subject to Sauda – ₹650
Expected Listing Gain – 4.49%
Anlon Healthcare IPO GMP Price to Down a high to low of ₹5 Rupay on Aug 28 and a High Price of ₹6 on Aug 25, 2025 Showing Strong Market demand.
Anlon Healthcare IPO GMP Live – Day-wise Trend ( Table)
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Profit |
|---|---|---|---|---|
| 28-08-2025 | ₹91 | ₹5 | ₹96 (6.59%) | ₹820 |
| 27-08-2025 | ₹91 | ₹5 | ₹96 (5.49%) | ₹820 |
| 26-08-2025 | ₹91 | ₹6 | ₹97 (6.59%) | ₹984 |
| 25-08-2025 | ₹91 | ₹6 | ₹97 (6.59%) | ₹984 |
| 24-08-2025 | ₹91 | ₹0 | ₹ (0.00%) | ₹0 |
| 23-08-2025 | ₹91 | ₹0 | ₹ (0.00%) | ₹0 |
| 22-08-2025 | ₹91 | ₹0 | ₹ (0.00%) | ₹0 |
| 21-08-2025 | ₹91 | ₹0 | ₹ (0.00%) | ₹0 |
Anlon Healthcare IPO Details
| IPO Open Date | Aug 26, 2025 |
|---|---|
| IPO Close Date | Aug 29, 2025 |
| IPO Price Band | ₹86 to ₹91 per share |
| Face Value | ₹10 per equity share |
| Lot Size | 164 Shares |
| Minimum Investment | ₹14,924 Thousand (for 1 lot at ₹91) |
| IPO Issue Type | Book Built Issue |
| IPO Issue Size | 1,33,00,000 shares (Approx ₹121.03 Cr) |
| Fresh Issue | 1,33,00,000 shares (Approx ₹121.03 Cr) |
| Retail Investor Quota | 35% |
| QIB Quota | 50% |
| NII (HNI) Quota | 15% |
| Listing Exchange | NSE BSE |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
About Anlon Healthcare Limited
Our Company was originally incorporated on November 19, 2013 as “Anlon Healthcare Limited” We are a chemical manufacturing company engaged in manufacturing of (i) high purity advance pharmaceutical intermediates (“Pharma Intermediate”) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients (ii) active pharmaceutical ingredients (“APIs”) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (“FDF”) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products
and animal health products.
Our products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
Our active pharmaceutical ingredient products are manufactured in accordance with Indian and international pharmacopeia standards such as IP, BP, EP, JP, USP.
We are one of the few manufacturers of loxoprofen sodium dihydrate in India, which is a notable API widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.
Also Read: Anlon Healthcare IPO 2025, Date, GMP, Price, Allotment, Review & Listing
FAQs ON Anlon Healthcare IPO GMP Today
Q1: What is Anlon Healthcare IPO GMP today?
Anlon Healthcare IPO GMP Price is ₹5 Per Share
Q2: What is the Kostak Rate today?
Anlon Healthcare IPO Kostak Rate is ₹- as of today Not available.
Q3: Anlon Healthcare ipo gmp investorgain?
Anlon Healthcare ipo gmp Price investorgain is ₹5 rupay Righ Now
Q4: Anlon Healthcare ipo gmp ipowatch?
Anlon Healthcare ipo gmp ipowatch Price is ₹6 rupay Righ Now
Q5: What is the Subject to Sauda rate?
Anlon Healthcare IPO Subject to Sauda is ₹650 as of today.
Q6: What are the expected listing gains?
Anlon Healthcare IPO Estimated 5.49% returns based on current GMP
Disclaimer:
IPO GMP (Grey Market Premium), Kostak and Subject to Sauda Rates are Unofficial and Can Change Quickly.
We do Not BUY or SELL IPO Forms.
Do Not apply For IPOs Based only on GMP Price.
Always Review the company’s fundamentals before investing.
